Complete AI-Based Treatment Process for Musculoskeletal Diseases

[INQ. NO. 2604E01] CONNECTEVE Co., Ltd. is a medical artificial intelligence (AI) company that digitally connects the entire treatment process of musculoskeletal diseases — from diagnosis, to surgery, and post-operative management — based on AI technology.
By combining more than 100,000 high-quality proprietary medical data cases with deep learning technology, CONNECTEVE has introduced CONNEVO KOA, CONNEVO Metric, and CONNEVO Suite. Recently, the company obtained European CE MDR certification and conducted PoC projects in the Middle East, demonstrating its technological capabilities in the global market and continuing its growth trajectory.

CONNECTEVE is expanding its clinical references centered on major tertiary hospitals in Korea. To implement its solutions, the company collaborates with Seoul National University Hospital, Chung-Ang University Hospital, Wonju Medical Center, Uijeongbu St. Mary’s Hospital, and CHA Bundang Medical Center.
An increasing number of adoption and demo requests are being received from secondary-level medical institutions. Overseas, active PoC projects are underway at Burjeel Hospital in the UAE and Tzu Chi Hospital in Indonesia, while clinical collaborations are being prepared with hospitals in advanced medical markets such as the United States, Japan, Singapore, Germany, and Belgium. This global network serves as a foundation for CONNECTEVE’s AI solutions to establish themselves as internationally recognized clinical tools.
CONNECTEVE’s CONNEVO Metric automatically measures lower-limb alignment and angular data, enabling data-based comparison of pre- and post-surgical changes. CONNEVO Suite integrates these diagnostic data and provides an environment optimized for clinical workflow, improving hospital operational efficiency. A key strength is its ability to reduce variability that may arise from manual measurement processes, and enable explanations based on objective numerical values.

CONNECTEVE has designated the Middle East (UAE), Southeast Asia (Indonesia and Singapore), and Europe (Germany and Belgium) as its key target markets. In the Middle East and Southeast Asia, where medical infrastructure modernization is rapidly progressing, demand for AI solutions that improve clinical efficiency is increasing. In Europe, the company is pursuing full-scale market entry based on CE MDR certification. Building on collaboration cases with regional flagship hospitals, CONNECTEVE plans to expand partnerships with global hospital chains and distribution partners.
Moving forward, CONNECTEVE will continue participating in major medical exhibitions and academic conferences in North America, Europe, and Asia to strengthen its global network ― while implementing localization strategies tailored to each country’s medical environment. With the goal of achieving orthopedic digital transformation that connects diagnosis to surgery, the company plans to expand R&D investment and advance as a global medical AI company providing a data-driven treatment environment for both physicians and patients.
 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods